Hospital
Sanford Health Network North
Sanford Health Network North was paid $3.28M by Medicaid between Jan 2018 and Dec 2024, across 75 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 40% of everything it billed.
33Billing provider infoSANFORD HEALTH NETWORK NORTH
THIEF RIVER FALLS, MN 56701
THIEF RIVER FALLS, MN 56701
33aNPI1043218753assigned 07/07/2005
33bProvider typeCritical Access Hospital
28Total paid$3.28M
24GClaims72,644
24DCodes billed75
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Minnesota
Rank by total paid#12 of 68
Median peer was paid$798K
This provider vs. median4.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MORRISON, TONY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,664 | $238K | |
| 2019 | 14,966 | $630K | |
| 2020 | 8,606 | $447K | |
| 2021 | 10,745 | $662K | |
| 2022 | 8,860 | $618K | |
| 2023 | 9,351 | $491K | |
| 2024incomplete | 4,452 | $192K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 40% | 19,958 | 15,599 | $1.30M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 9,297 | 6,674 | $471K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 2,894 | 2,566 | $368K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.7% | 550 | 434 | $187K |
| 36415 | Collection of venous blood by venipuncture | 3.5% | 16,762 | 13,955 | $113K |
| 80053 | Comprehensive metabolic panel | 3.0% | 2,882 | 2,570 | $97K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.6% | 477 | 444 | $84K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 2.5% | 1,297 | 1,095 | $81K |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | 2.1% | 2,304 | 1,394 | $68K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.1% | 3,510 | 3,057 | $68K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 1.7% | 1,343 | 735 | $55K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.5% | 483 | 436 | $49K |
63 more codes
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.4% | 716 | $47K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.2% | 540 | $40K |
| 80061 | Lipid panel | 1.1% | 1,137 | $38K |
| J3490 | Unclassified drugs | <1% | 736 | $20K |
| 98940 | <1% | 866 | $17K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 247 | $16K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 167 | $14K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 245 | $12K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 100 | $10K |
| 0001A | <1% | 342 | $9K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 438 | $9K |
| 0002A | <1% | 308 | $8K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 607 | $8K |
| 81001 | <1% | 467 | $7K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 146 | $6K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 117 | $5K |
| 86140 | <1% | 275 | $5K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 199 | $5K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 48 | $5K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 194 | $4K |
| 59025 | Fetal non-stress test | <1% | 20 | $4K |
| 87510 | <1% | 204 | $4K | |
| 87660 | <1% | 204 | $3K | |
| 87480 | <1% | 204 | $3K | |
| 11721 | <1% | 191 | $3K | |
| 90686 | <1% | 454 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 103 | $3K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 28 | $2K |
| 82728 | <1% | 109 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 41 | $2K |
| 82607 | <1% | 107 | $2K | |
| 83735 | <1% | 160 | $2K | |
| 85027 | <1% | 81 | $2K | |
| 82043 | <1% | 59 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 31 | $2K |
| 82570 | <1% | 78 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 50 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 13 | $1K |
| Q3014 | Telehealth originating site facility fee | <1% | 52 | $1K |
| 0004A | <1% | 45 | $1K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 51 | $1K |
| 84484 | <1% | 47 | $906.41 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 56 | $876.35 |
| 0124A | <1% | 40 | $814.31 | |
| 71045 | Radiologic examination, chest; single view | <1% | 13 | $787.15 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 37 | $728.32 |
| 83605 | <1% | 29 | $698.39 | |
| 80069 | <1% | 17 | $618.13 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 13 | $594.33 |
| 85610 | <1% | 39 | $531.74 | |
| 0352U | <1% | 46 | $490.60 | |
| 80306 | <1% | 38 | $481.88 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 63 | $433.28 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 29 | $311.69 |
| 85652 | <1% | 30 | $297.88 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 57 | $268.23 |
| G0008 | Administration of influenza virus vaccine | <1% | 21 | $182.77 |
| 84156 | <1% | 17 | $146.14 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 29 | $77.88 |
| 99188 | <1% | 12 | $74.68 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 12 | $33.44 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 15 | $20.57 |
| 91300 | <1% | 47 | $20.09 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMORRISON, TONY (VICE PRESIDENT, REVENUE CYCLE)
| Provider | Location | Paid |
|---|---|---|
| Sanford Medical Center Fargo | Fargo, ND | $50.18M |
| Sanford Health of Northern Minnesota | Bemidji, MN | $47.45M |
| Sanford Bismarck | Bismarck, ND | $43.96M |
| Sanford Health of Northern Minnesota | Bemidji, MN | $27.11M |
| Sanford Medical Center | Sioux Falls, SD | $24.40M |
| FM Ambulance Service, INC | Fargo, ND | $23.80M |
| Sanford Medical Center | Sioux Falls, SD | $18.03M |
| Sanford Health Network | Worthington, MN | $7.58M |
| Sanford Clinic | Sioux Falls, SD | $6.04M |
| Sanford Clinic | Sioux Falls, SD | $5.45M |
| Sanford Healthcare Accessories, LLC | Fargo, ND | $4.79M |
| Sanford Clinic | Sioux Falls, SD | $2.96M |
| Sanford Health Network | Jackson, MN | $2.81M |
| Sanford Clinic | Watertown, SD | $2.02M |
| Black Hills Orthopedic & Spine Center, INC. | Rapid City, SD | $1.71M |
| Sanford Health Network | Chamberlain, SD | $1.47M |
| Sanford Health Network | Vermillion, SD | $1.31M |
| Sanford Health Network | Luverne, MN | $1.27M |
| Sanford Medical Center Fargo | Pelican Rapids, MN | $1.01M |
| Sanford Medical Center Fargo | Mahnomen, MN | $994K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.